This inventor holds 1 USPTO granted patent. Top assignee: Liangjiang Medicine Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xiaoli Shen and Sustained-Release Prodrug Innovation.
Introduction
Xiaoli Shen is an inventor based in Chongqing, China. Her work includes a patent concerning prodrugs designed to provide sustained release of therapeutic agents.
Latest Patents
Shen is associated with 1 patent: “Prodrugs for Sustained Releasing Therapeutic Agents and Uses Thereof.” The patent describes prodrug compounds formed from a parent drug moiety and a covalently linked tail moiety. It addresses parent drugs with reactive groups such as amine, amino, hydroxyl, carboxylate, ketone, or amide groups. The disclosure also covers pharmaceutical compositions containing the prodrugs or their pharmaceutically acceptable salts, as well as methods for treating diseases.
Career Highlights
Shen is associated with Liangjiang Medicine Co., Ltd. The patent reflects work on prodrug design and potential approaches to sustained therapeutic delivery.
Collaborations
The listed coworkers associated with Shen include Liyan Xu and Yong Liu.
Conclusion
Xiaoli Shen’s patent work focuses on prodrug compounds and their potential use in sustained-release therapies, connecting her innovation to pharmaceutical research at Liangjiang Medicine Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile